List of Tables
Table 1. Global Influenza Drugs and Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Influenza Drugs and Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Influenza Drugs and Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Influenza Drugs and Vaccines Sales (Tons) of Key Manufacturers (2020-2025)
Table 5. Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Influenza Drugs and Vaccines Average Price (US$/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Influenza Drugs and Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Influenza Drugs and Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Influenza Drugs and Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Influenza Drugs and Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs and Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Influenza Drugs and Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Influenza Drugs and Vaccines Sales by Region (2020-2025) & (Tons)
Table 18. Global Influenza Drugs and Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Influenza Drugs and Vaccines Sales by Region (2026-2031) & (Tons)
Table 20. Global Influenza Drugs and Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Influenza Drugs and Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Influenza Drugs and Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Influenza Drugs and Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Influenza Drugs and Vaccines Sales by Country (2020-2025) & (Tons)
Table 27. North America Influenza Drugs and Vaccines Sales by Country (2026-2031) & (Tons)
Table 28. North America Influenza Drugs and Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Influenza Drugs and Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Influenza Drugs and Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Influenza Drugs and Vaccines Sales by Country (2020-2025) & (Tons)
Table 32. Europe Influenza Drugs and Vaccines Sales by Country (2026-2031) & (Tons)
Table 33. Europe Influenza Drugs and Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Influenza Drugs and Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Influenza Drugs and Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2020-2025) & (Tons)
Table 37. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2026-2031) & (Tons)
Table 38. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Influenza Drugs and Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Influenza Drugs and Vaccines Sales by Country (2020-2025) & (Tons)
Table 42. Latin America Influenza Drugs and Vaccines Sales by Country (2026-2031) & (Tons)
Table 43. Latin America Influenza Drugs and Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Influenza Drugs and Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2020-2025) & (Tons)
Table 47. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2026-2031) & (Tons)
Table 48. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Influenza Drugs and Vaccines Sales (Tons) by Type (2020-2025)
Table 51. Global Influenza Drugs and Vaccines Sales (Tons) by Type (2026-2031)
Table 52. Global Influenza Drugs and Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Influenza Drugs and Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Influenza Drugs and Vaccines Price (US$/Kg) by Type (2020-2025)
Table 59. Global Influenza Drugs and Vaccines Price (US$/Kg) by Type (2026-2031)
Table 60. Global Influenza Drugs and Vaccines Sales (Tons) by Application (2020-2025)
Table 61. Global Influenza Drugs and Vaccines Sales (Tons) by Application (2026-2031)
Table 62. Global Influenza Drugs and Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Influenza Drugs and Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Influenza Drugs and Vaccines Price (US$/Kg) by Application (2020-2025)
Table 69. Global Influenza Drugs and Vaccines Price (US$/Kg) by Application (2026-2031)
Table 70. CSL Company Information
Table 71. CSL Description and Business Overview
Table 72. CSL Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 73. CSL Influenza Drugs and Vaccines Product
Table 74. CSL Recent Developments/Updates
Table 75. Bristol Myers Squibb Company Information
Table 76. Bristol Myers Squibb Description and Business Overview
Table 77. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 78. Bristol Myers Squibb Influenza Drugs and Vaccines Product
Table 79. Bristol Myers Squibb Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 83. AstraZeneca Influenza Drugs and Vaccines Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Eli Lilly Company Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 88. Eli Lilly Influenza Drugs and Vaccines Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Roche Company Information
Table 91. Roche Description and Business Overview
Table 92. Roche Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. Roche Influenza Drugs and Vaccines Product
Table 94. Roche Recent Developments/Updates
Table 95. GlaxoSmithKline Company Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Influenza Drugs and Vaccines Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Novartis Company Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 103. Novartis Influenza Drugs and Vaccines Product
Table 104. Novartis Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 108. Pfizer Influenza Drugs and Vaccines Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Sanofi Company Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 113. Sanofi Influenza Drugs and Vaccines Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Bayer Company Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 118. Bayer Influenza Drugs and Vaccines Product
Table 119. Bayer Recent Developments/Updates
Table 120. Celgene Company Information
Table 121. Celgene Description and Business Overview
Table 122. Celgene Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 123. Celgene Influenza Drugs and Vaccines Product
Table 124. Celgene Recent Developments/Updates
Table 125. Seqirus Company Information
Table 126. Seqirus Description and Business Overview
Table 127. Seqirus Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 128. Seqirus Influenza Drugs and Vaccines Product
Table 129. Seqirus Recent Developments/Updates
Table 130. Protein Sciences Corporation Company Information
Table 131. Protein Sciences Corporation Description and Business Overview
Table 132. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 133. Protein Sciences Corporation Influenza Drugs and Vaccines Product
Table 134. Protein Sciences Corporation Recent Developments/Updates
Table 135. Serum Institute of India Company Information
Table 136. Serum Institute of India Description and Business Overview
Table 137. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 138. Serum Institute of India Influenza Drugs and Vaccines Product
Table 139. Serum Institute of India Recent Developments/Updates
Table 140. Emergent Biosolutions Company Information
Table 141. Emergent Biosolutions Description and Business Overview
Table 142. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 143. Emergent Biosolutions Influenza Drugs and Vaccines Product
Table 144. Emergent Biosolutions Recent Developments/Updates
Table 145. BioCryst Pharmaceuticals Company Information
Table 146. BioCryst Pharmaceuticals Description and Business Overview
Table 147. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 148. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product
Table 149. BioCryst Pharmaceuticals Recent Developments/Updates
Table 150. Alvogen Company Information
Table 151. Alvogen Description and Business Overview
Table 152. Alvogen Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 153. Alvogen Influenza Drugs and Vaccines Product
Table 154. Alvogen Recent Developments/Updates
Table 155. Viatris Company Information
Table 156. Viatris Description and Business Overview
Table 157. Viatris Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 158. Viatris Influenza Drugs and Vaccines Product
Table 159. Viatris Recent Developments/Updates
Table 160. Hulan Bio Company Information
Table 161. Hulan Bio Description and Business Overview
Table 162. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 163. Hulan Bio Influenza Drugs and Vaccines Product
Table 164. Hulan Bio Recent Developments/Updates
Table 165. Changchun Institute of Biological Company Information
Table 166. Changchun Institute of Biological Description and Business Overview
Table 167. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 168. Changchun Institute of Biological Influenza Drugs and Vaccines Product
Table 169. Changchun Institute of Biological Recent Developments/Updates
Table 170. Jiangsu GDK Company Information
Table 171. Jiangsu GDK Description and Business Overview
Table 172. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 173. Jiangsu GDK Influenza Drugs and Vaccines Product
Table 174. Jiangsu GDK Recent Developments/Updates
Table 175. Sinovac Company Information
Table 176. Sinovac Description and Business Overview
Table 177. Sinovac Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 178. Sinovac Influenza Drugs and Vaccines Product
Table 179. Sinovac Recent Developments/Updates
Table 180. Beike Bio Company Information
Table 181. Beike Bio Description and Business Overview
Table 182. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 183. Beike Bio Influenza Drugs and Vaccines Product
Table 184. Beike Bio Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Influenza Drugs and Vaccines Distributors List
Table 188. Influenza Drugs and Vaccines Customers List
Table 189. Influenza Drugs and Vaccines Market Trends
Table 190. Influenza Drugs and Vaccines Market Drivers
Table 191. Influenza Drugs and Vaccines Market Challenges
Table 192. Influenza Drugs and Vaccines Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
Table 196. Authors List of This Report
List of Figures
Figure 1. Product Picture of Influenza Drugs and Vaccines
Figure 2. Global Influenza Drugs and Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Influenza Drugs and Vaccines Market Share by Type: 2024 & 2031
Figure 4. Influenza Drugs Product Picture
Figure 5. Influenza Vaccines Product Picture
Figure 6. Global Influenza Drugs and Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Influenza Drugs and Vaccines Market Share by Application: 2024 & 2031
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Influenza Drugs and Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Influenza Drugs and Vaccines Market Size (2020-2031) & (US$ Million)
Figure 13. Global Influenza Drugs and Vaccines Sales (2020-2031) & (Tons)
Figure 14. Global Influenza Drugs and Vaccines Average Price (US$/Kg) & (2020-2031)
Figure 15. Influenza Drugs and Vaccines Report Years Considered
Figure 16. Influenza Drugs and Vaccines Sales Share by Manufacturers in 2024
Figure 17. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Influenza Drugs and Vaccines Players: Market Share by Revenue in Influenza Drugs and Vaccines in 2024
Figure 19. Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Influenza Drugs and Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Influenza Drugs and Vaccines Sales Market Share by Country (2020-2031)
Figure 22. North America Influenza Drugs and Vaccines Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2020-2031)
Figure 26. Europe Influenza Drugs and Vaccines Revenue Market Share by Country (2020-2031)
Figure 27. Germany Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Region (2020-2031)
Figure 34. China Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Influenza Drugs and Vaccines Sales Market Share by Country (2020-2031)
Figure 45. Latin America Influenza Drugs and Vaccines Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Influenza Drugs and Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Influenza Drugs and Vaccines by Type (2020-2031)
Figure 55. Global Revenue Market Share of Influenza Drugs and Vaccines by Type (2020-2031)
Figure 56. Global Influenza Drugs and Vaccines Price (US$/Kg) by Type (2020-2031)
Figure 57. Global Sales Market Share of Influenza Drugs and Vaccines by Application (2020-2031)
Figure 58. Global Revenue Market Share of Influenza Drugs and Vaccines by Application (2020-2031)
Figure 59. Global Influenza Drugs and Vaccines Price (US$/Kg) by Application (2020-2031)
Figure 60. Influenza Drugs and Vaccines Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
